Eton Pharmaceuticals, Inc. (ETON) Financials

$13.70

$0.09 (0.66%)
Last update: 04:00 PM EST
Day's range
$13.2
Day's range
$13.88
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40MEarning201820182019201920202020202120212022202220232023202420240%0%-20000%-20000%-40000%-40000%-60000%-60000%-80000%-80000%Profit Margin
Profit Margin
Revenue
Earnings

ETON Income statement / Annual

Last year (2024), Eton Pharmaceuticals, Inc.'s total revenue was $39.01 M, an increase of 23.29% from the previous year. In 2024, Eton Pharmaceuticals, Inc.'s net income was -$3.82 M. See Eton Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $39.01 M $31.64 M $21.25 M $21.83 M $39.00 K $959.00 K $0.00 $0.00
Cost of Revenue $15.60 M $10.58 M $6.93 M $2.62 M $286.00 K $453.00 K $63.00 K $13.00 K
Gross Profit $23.41 M $21.06 M $14.32 M $19.21 M -$247.00 K $506.00 K -$63.00 K -$13.00 K
Gross Profit Ratio 0.6 0.67 0.67 0.88 -6.33 0.53 0 0
Research and Development Expenses $3.26 M $3.32 M $4.00 M $6.24 M $14.10 M $11.56 M $5.63 M $3.93 M
General & Administrative Expenses $22.75 M $18.93 M $18.58 M $14.47 M $12.76 M $7.55 M $4.69 M $4.83 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$1.62 M
Selling, General & Administrative Expenses $22.75 M $18.93 M $18.58 M $14.47 M $12.76 M $7.55 M $4.69 M $3.21 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $26.01 M $22.25 M $22.58 M $20.70 M $26.86 M $19.11 M $10.32 M $7.14 M
Cost And Expenses $41.61 M $32.83 M $29.51 M $23.33 M $27.15 M $19.56 M $10.32 M $7.15 M
Interest Income $0.00 $0.00 $761.00 K $1.01 M $859.00 K $281.00 K $164.00 K $52.50 K
Interest Expense $2.01 M $0.00 $955.00 K $1.01 M $889.00 K $0.00 $0.00 $0.00
Depreciation & Amortization $1.15 M $901.00 K $1.77 M $447.00 K $651.00 K $447.00 K $63.00 K $13.00 K
EBITDA -$1.45 M -$291.00 K -$6.49 M -$1.12 M -$26.46 M -$18.15 M -$10.26 M -$7.14 M
EBITDA Ratio -0.04 -0.01 -0.31 -0.05 -678.46 -18.93 0 0
Operating Income Ratio -0.07 -0.04 -0.39 -0.07 -695.15 -19.4 0 0
Total Other Income/Expenses Net -$1.21 M $503.00 K -$761.00 K -$460.00 K -$859.00 K $281.00 K -$2.42 M -$6.00 K
Income Before Tax -$3.81 M -$689.00 K -$9.02 M -$1.96 M -$27.97 M -$18.32 M -$12.74 M -$7.16 M
Income Before Tax Ratio -0.1 -0.02 -0.42 -0.09 -717.18 -19.1 0 0
Income Tax Expense $15.00 K $247.00 K $761.00 K $1.01 M $859.00 K -$281.00 K -$2.58 M $0.00
Net Income -$3.82 M -$936.00 K -$9.78 M -$2.96 M -$28.83 M -$18.04 M -$12.74 M -$7.16 M
Net Income Ratio -0.1 -0.03 -0.46 -0.14 -739.21 -18.81 0 0
EPS -0.15 -0.0365 -0.39 -0.12 -1.37 -1.02 -1.99 -0.41
EPS Diluted -0.15 -0.0365 -0.39 -0.12 -1.37 -1.02 -1.99 -0.41
Weighted Average Shares Out $25.90 M $25.65 M $25.15 M $25.21 M $21.01 M $17.76 M $6.42 M $17.46 M
Weighted Average Shares Out Diluted $25.90 M $25.65 M $25.15 M $25.21 M $21.01 M $17.76 M $6.42 M $17.46 M
Link